Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer, April 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 229 articles:
HTML format


 

Single Articles

  1. ZHANG Y, Li C, Xiang Y
    Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications.
    Biochim Biophys Acta Rev Cancer. 2026 Apr 1:189581.
    PubMed    
    Abstract available

  2. SAINI K, Saini A, Yadav N, Kumar V, et al
    Emerging frontiers in cervical cancer diagnostics: Recent innovations in biosensors for HPV detection.
    Talanta. 2026;306:129750.
    PubMed    
    Abstract available

  3. YI J, Xu C, Huo Z, Zhou H, et al
    MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.
    Recent Pat Anticancer Drug Discov. 2026.
    PubMed    
    Abstract available

  4. JIN W, Wang X, Fan Y, Huang C, et al
    A preference study for applying mHealth to improve the quality of cervical cancer screening management from a supply and demand perspective: a discrete choice experiment.
    Cancer Causes Control. 2026;37:70.
    PubMed    
    Abstract available

  5. BAO YH, Xiao ML, Li YA, Ma FH, et al
    Multiparametric MRI-based Deep Learning and Radiomics for Evaluating Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Radiol Imaging Cancer. 2026;8:e250345.
    PubMed    
    Abstract available

  6. DU Q, Liu Q, Zhou Y, Kong Y, et al
    Primary prophylaxis with pegylated G-CSF is associated with improved treatment completion and progression-free survival in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study.
    Future Oncol. 2026 Apr 3:1-10. doi: 10.1080/14796694.2026.2654729.
    PubMed    
    Abstract available

  7. MATSUKAWA H, Yugawa K, Hosokawa C, Furuichi K, et al
    Hyperspectral Imaging of Whole-Cell Region for Differentiating Cervical Squamous Intraepithelial Lesion Cytology.
    Cancer Med. 2026;15:e71746.
    PubMed    
    Abstract available

  8. CHU C, Du Z, Wang J, Aili M, et al
    Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer.
    Int J Nanomedicine. 2026;21:576589.
    PubMed    
    Abstract available

  9. KITONSA J, Kafeero P, Ankunda V, Muhumuza R, et al
    Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.
    Hum Vaccin Immunother. 2026;22:2654928.
    PubMed    
    Abstract available

  10. ABUZOOR A, Jabin MSR, Jonker C
    Health Beliefs and Perspectives of Parents Regarding Human Papillomavirus Vaccination in Kuwait: Qualitative Study.
    JMIR Form Res. 2026;10:e85438.
    PubMed    
    Abstract available

  11. NAZAROVA V, Kamzayeva N, Ukybassova T, Kozhakhmetov S, et al
    Systems analysis of the HPV-microbiome-biofilm triad.
    Front Cell Infect Microbiol. 2026;16:1767224.
    PubMed    
    Abstract available

  12. FANG Y, Bai J, Bo S, Cui X, et al
    Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in human cervical cancer cells.
    Front Pharmacol. 2026;17:1544170.
    PubMed    
    Abstract available

  13. MANICKAM R, Karnik M, Madhunapantula SV, Mohideen HS, et al
    Human CLIC5 as a Recurrent Hotspot of HPV 16 Integration in Cervical Cancer.
    J Med Virol. 2026;98:e70897.
    PubMed    
    Abstract available

  14. NAKAJIMA K, Otsuka Y, Ikejiri T, Hakariya H, et al
    Evaluating the "Praise Movement" on Social Media: Perceptions of the Human Papillomavirus Vaccine in Japan.
    Yakugaku Zasshi. 2026;146:339-343.
    PubMed    
    Abstract available

  15. JI L, Zhou X, Yao L
    Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: Qualitative Study Based on the Macro Model of Health System.
    J Med Internet Res. 2026;28:e75372.
    PubMed    
    Abstract available

  16. ABE K, Ito K, Watanabe M, Tsuneda M, et al
    Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study.
    J Radiat Res. 2026 Apr 1:rrag013. doi: 10.1093.
    PubMed    
    Abstract available

  17. ZHANG M, Gao L, Bai X
    Health-related hardiness and influencing factors among cervical cancer radiotherapy patients: A cross-sectional study.
    Support Care Cancer. 2026;34:394.
    PubMed    
    Abstract available

  18. SINGH P, Sharma K, Tamrakar VK, Khare R, et al
    CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.
    Expert Rev Mol Diagn. 2026 Apr 1. doi: 10.1080/14737159.2026.2654503.
    PubMed    
    Abstract available

  19. XIAOYAN Z, Xiaojuan L, Shijiao M, Xiaofan Z, et al
    Baseline inflammatory and metabolic indicators associated with early PD-1 inhibitor resistance in advanced cervical cancer: a retrospective cohort study.
    Front Med (Lausanne). 2026;13:1779898.
    PubMed    
    Abstract available

  20. LU X, Su Y, Xu W, Tang T, et al
    Efficacy of induction chemotherapy combined with standard chemoradiotherapy vs. standard chemoradiotherapy monotherapy in locally advanced cervical cancer: A systematic review and meta-analysis.
    Oncol Lett. 2026;31:183.
    PubMed    
    Abstract available

  21. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
    Burden and predictors of cervical cancer mortality in Sub-Saharan Africa: a systematic review and meta-analysis.
    Infect Agent Cancer. 2026 Mar 31. doi: 10.1186/s13027-026-00749.
    PubMed    


  22. FEROZ B, Ebner C, Skvortsov S, Purtscheller R, et al
    Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.
    Radiat Oncol. 2026 Mar 31. doi: 10.1186/s13014-026-02834.
    PubMed    


  23. MOHAN N
    HPV Vaccination: A Transformative Step Towards Eliminating Cervical Cancer in India.
    Indian Pediatr. 2026 Mar 31. doi: 10.1007/s13312-026-00326.
    PubMed    


  24. WANG D, He J, Wu S, Liu S, et al
    UM-6 remodels the tumor immune microenvironment by blocking PD-L1 N-glycosylation and promoting ERAD-mediated degradation in cervical cancer.
    Bioorg Chem. 2026;175:109788.
    PubMed    
    Abstract available

  25. GARG S, Udayashankara AH, S N, F HNA, et al
    Pain management and analgesic strategies in patients with carcinoma uterine cervix undergoing intracavitary or interstitial brachytherapy.
    Support Care Cancer. 2026;34:391.
    PubMed    
    Abstract available

  26. YUILL S, Naidu C, Smith M, Bateson D, et al
    Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers.
    Med J Aust. 2026;224:e70164.
    PubMed    
    Abstract available

  27. ABBAS G, Bokhari TH, Iqbal MA, Rehman S, et al
    Mechanosynthesis and computational studies of new imidazole-based selenium adducts as potential anticancer agents against human prostate and cervical cancer.
    Future Med Chem. 2026 Mar 31:1-11. doi: 10.1080/17568919.2026.2648984.
    PubMed    
    Abstract available

  28. SATO K, Oshima N, Onuki M, Matsumoto K, et al
    Psychosocial Burden of Women With Cervical Intraepithelial Neoplasia in Japan: Results of A Web-Based Survey.
    J Obstet Gynaecol Res. 2026;52:e70258.
    PubMed    
    Abstract available

  29. YAO Q, Wang K, Liu B, Jiang P, et al
    Integrated optimization of needle paths and dwell time for individualized template-guided interstitial brachytherapy.
    Med Phys. 2026;53:e70411.
    PubMed    
    Abstract available

  30. SU R, Wang Y
    CLO26-078: Impact of Laparoscopic Surgical Proficiency on Survival Outcomes in Laparoscopic Radical Hysterectomy for Cervical Cancer.
    J Natl Compr Canc Netw. 2026;24.
    PubMed    


  31. CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
    EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
    J Natl Compr Canc Netw. 2026;24.
    PubMed    


  32. GANDHI AK, Rastogi M, Sharma V, Bhutia TD, et al
    Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study.
    J Cancer Res Ther. 2026;22:84-89.
    PubMed    
    Abstract available

  33. SINDHU KR, Pranitha SL, Arpitha S, Narayanan GS, et al
    Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.
    J Cancer Res Ther. 2026;22:27-35.
    PubMed    
    Abstract available

  34. ZHAO Z, Sun C, Liu X, Yu P, et al
    GSTO1 Promotes Cell Proliferation and Stemness of Cervical Cancer via Activating PI3K/AKT/mTOR Pathway.
    FASEB J. 2026;40:e71702.
    PubMed    
    Abstract available

  35. MEIRELLES I, Pinto M, Russomano F
    Cost-utility of screening with liquid cytology or p16/Ki67 dual-stain in women identified in cervical cancer screening with non 16/18 HR-HPV.
    Int J Technol Assess Health Care. 2026.
    PubMed    


  36. TANG J, Oska C, Xie X, Small I, et al
    Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost.
    Cureus. 2026;18:e104301.
    PubMed    
    Abstract available

  37. O'NEILL H, Bruegl A
    Immunotherapy induced sarcoidosis in a 47-year-old female with stage IIIC cervical cancer on pembrolizumab: A case report.
    Gynecol Oncol Rep. 2026;64:102062.
    PubMed    
    Abstract available

  38. LI G, Chen N, Li X, Deng D, et al
    Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
    Int J Womens Health. 2026;18:595680.
    PubMed    
    Abstract available

  39. HUANG X, Zhou C, Ou Y
    Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer.
    Front Surg. 2026;13:1775199.
    PubMed    
    Abstract available

  40. LIU J, Ren WJ
    Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report.
    Front Oncol. 2026;16:1736364.
    PubMed    
    Abstract available

  41. LI S, Wang N
    The correlation between the triglyceride-glucose index and the odds of cervical cancer.
    Front Oncol. 2026;16:1766167.
    PubMed    
    Abstract available

  42. DUSHKIN A, Grishacheva T, Afanasiev S, Dushkina I, et al
    One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins.
    J Gynecol Oncol. 2026 Mar 18. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  43. HAN KH, Yang E, Kim N, Son JH, et al
    Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002).
    J Gynecol Oncol. 2026 Mar 12. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  44. GOTLIB-MALKOWSKA J, Debska M
    Effectiveness of ChatGPT in simplifying information for Polish patients on cervical cancer screening using advanced prompting.
    Ann Agric Environ Med. 2026;33:46-52.
    PubMed    
    Abstract available

  45. RAKHMANOVA M, Sakko Y, Suleimenova A, Sakhipova G, et al
    Patient acceptance of HPV self-sampling approach for cervical cancer screening: evidence from a pilot study in Kazakhstan.
    Ann Med. 2026;58:2645175.
    PubMed    
    Abstract available

  46. CASTLE PE
    Declining cervical cancer incidence in young women living in the United States: is it time to stop screening them?
    J Natl Cancer Inst. 2026 Mar 29:djag041. doi: 10.1093.
    PubMed    


  47. TANG W, Ma H, Li J, Kuang Y, et al
    Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells.
    J Transl Med. 2026 Mar 28. doi: 10.1186/s12967-026-08031.
    PubMed    


  48. HALLSSON LR, Hoflacher AM, Stratil J, Muehler M, et al
    Cost-effectiveness studies evaluating HPV self-sampling for cervical cancer screening - a systematic review.
    BMC Health Serv Res. 2026 Mar 28. doi: 10.1186/s12913-026-14409.
    PubMed    


  49. ENDALEW A, Kassahun M, Habtegiorgis SD, Tsega TD, et al
    Determinants of precancerous cervical lesion among HIV positive women on ART in Awi zone public health facilities, Northwest Ethiopia, 2024.
    Sci Rep. 2026;16:10729.
    PubMed    
    Abstract available

  50. LUO J, Lin Y, Yi Q, Long Y, et al
    Efficacy of focused ultrasound for HPV clearance and cervical LSIL treatment: a meta-analysis.
    Sci Rep. 2026;16:10747.
    PubMed    
    Abstract available

  51. WU X, Zhang H, Yang X, Li Z, et al
    Rechallenging Immunotherapy With Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Achieved Partial Response in a Heavily Treated Patient With Metastatic Cervical Cancer: Case Report.
    Clin Ther. 2026 Mar 27:S0149-2918(26)00069.
    PubMed    


  52. MALISZEWSKI B, Ignaczak A, Skonieczna B, Pastuszynski A, et al
    Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines.
    Chem Biol Interact. 2026;432:112062.
    PubMed    
    Abstract available

  53. SHEN J, Miao Z, Wang L, Huo Z, et al
    Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information.
    IET Syst Biol. 2026;20:e70060.
    PubMed    
    Abstract available

  54. CSIKOS C, Ngo MT, Vagner A, Nagy G, et al
    Enhanced Tumor-to-Background Contrast with [(52)Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
    Pharmaceuticals (Basel). 2026;19:517.
    PubMed    
    Abstract available

  55. LI J, Parhat P, Ma Y, Peng L, et al
    Exploring the Anti-Cervical Cancer Effect and Hepatotoxicity Risk of Gossypol Based on Untargeted Metabolomics and Network Toxicology.
    Pharmaceuticals (Basel). 2026;19:377.
    PubMed    
    Abstract available

  56. GIORGIO V, Del Dotto V, Grandi M, Grillini S, et al
    Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.
    Life (Basel). 2026;16:450.
    PubMed    
    Abstract available

  57. ZHAO S, Yang X, Zhang L, Yang D, et al
    Correlation Between Dosimetric Parameters and Hematologic Toxicity in Cervical Cancer Patients Undergoing Intensity-Modulated Pelvic Radiotherapy.
    Cancers (Basel). 2026;18:992.
    PubMed    
    Abstract available

  58. ELSAYIM R, Alhamdi HW, Almuraikhi N, Alkhateeb MA, et al
    Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.
    Genes (Basel). 2026;17:281.
    PubMed    
    Abstract available

  59. MOLNAR O, Mihutiu S, Straciuc OM, Vesa A, et al
    Correction: Molnar et al. PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the Literature. Biomedicines 2025, 13, 83.
    Biomedicines. 2026;14:676.
    PubMed    
    Abstract available

  60. TAN L, Li H, Liu T, Mao W, et al
    Perineural Invasion in Early-Stage Cervical Cancer: Marker of Aggressive Pathology and Increased Recurrence Risk.
    Biomedicines. 2026;14:591.
    PubMed    
    Abstract available

  61. PRETI M, Gallio N, Costa S, Borella F, et al
    Opportunistic and Organized Cervical Cancer Screening: Impact on Lesion Severity and Surgical Outcomes in 9830 Cervical Conizations.
    Diagnostics (Basel). 2026;16:839.
    PubMed    
    Abstract available

  62. YANG T, Guo L, Liu D, Hua K, et al
    Proteome-based molecular subtyping and therapeutic target prediction in cervical cancer.
    Biomark Res. 2026;14:35.
    PubMed    
    Abstract available

  63. SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
    Correction: Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
    Radiat Oncol. 2026;21:42.
    PubMed    


  64. BRIN M, Caraballo PB, Ramirez SO, Guzman L, et al
    Evaluation of a patient educational brochure to increase knowledge of cervical cancer screening among women living with HIV in La Romana.
    BMC Public Health. 2026 Mar 28. doi: 10.1186/s12889-026-27029.
    PubMed    


  65. HACHIMI SE, Essayagh F, Essayagh M, Kazadi GB, et al
    Assessing the prevalence of non-use of cervical cancer screening in Khouribga, Morocco.
    Sci Rep. 2026;16:10858.
    PubMed    
    Abstract available

  66. SARKAR S, Saha A, DAS B, DAS D, et al
    Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV(+) Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation.
    Anticancer Res. 2026;46:2007-2024.
    PubMed    
    Abstract available

  67. PARKER JM, Williams LR, Haines NA, Mayberry TG, et al
    Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer.
    Anticancer Res. 2026;46:1833-1841.
    PubMed    
    Abstract available

  68. WANG H, Luo C, Chen W, Wang Y, et al
    Folic acid-decorated chitosan nanoparticles co-delivering silymarin and docetaxel induce CDK-mediated cell cycle arrest and apoptosis in cervical cancer cell.
    Int J Biol Macromol. 2026 Mar 25:151668. doi: 10.1016/j.ijbiomac.2026.151668.
    PubMed    
    Abstract available

  69. NARESH KUMAR A, Sageengran S, Mahalle PN, Guganathan L, et al
    Cervical cancer image analysis: Detection and segmentation using self-guided quantum GANs and musical chairs optimization.
    Comput Biol Med. 2026;208:111633.
    PubMed    
    Abstract available

  70. YANG T, Zhang T, Yan W, Chen X, et al
    DWI-derived intratumoral, peritumoral, and habitat features for preoperative prediction of lymph node metastasis in early-stage cervical cancer using machine learning method.
    Abdom Radiol (NY). 2026 Mar 27. doi: 10.1007/s00261-026-05463.
    PubMed    
    Abstract available

  71. BIEDERMAN EB, Champion VL, Head KJ, Imburgia TM, et al
    Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women.
    Vaccines (Basel). 2026;14:251.
    PubMed    
    Abstract available

  72. PANCZEL I, Herold M, Borbenyi E, Horanyi D, et al
    Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-Analysis.
    Med Sci (Basel). 2026;14:105.
    PubMed    
    Abstract available

  73. TANAKA YO
    A Novel, Promising Technique for Metastatic Lymph Node Detection in Uterine Cervical Cancer.
    Radiol Imaging Cancer. 2026;8:e260111.
    PubMed    


  74. BROOK E, Patterson K, Wijenayake N, Madin-Warburton M, et al
    The broad societal value of pembrolizumab for women's cancer in Canada.
    Future Oncol. 2026;22:939-952.
    PubMed    
    Abstract available

  75. SATAKE M, Ito S, Sawano C, Scuffham P, et al
    Benefit-risk assessment of HPV vaccination programs in Australia, the United States, and Japan.
    Vaccine. 2026;78:128407.
    PubMed    
    Abstract available

  76. TAN LT, Gregory DL, Prewett S, Duke SL, et al
    Long-term Clinical Outcomes of a Resource-conserving Accelerated Magnetic Resonance Imaging-guided Brachytherapy Schedule for Cervix Cancer.
    Clin Oncol (R Coll Radiol). 2026;52:104057.
    PubMed    
    Abstract available

  77. GUPTA K, Mandal S, Singh M, Mala YM, et al
    The expression of p16 , epidermal growth factor receptor and CD44 in squamous cell carcinoma uterine cervix.
    Indian J Pathol Microbiol. 2026;69:48-53.
    PubMed    
    Abstract available

  78. CHU K, Vidali S, Parberry A, Saull M, et al
    Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched Study.
    BJOG. 2026;133:1262-1270.
    PubMed    
    Abstract available

  79. JIA X, Da X, Shi J, Chen M, et al
    Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study.
    Cancer Epidemiol Biomarkers Prev. 2026;35:528-539.
    PubMed    
    Abstract available

  80. VIEIRA-BAPTISTA P, Lima-Silva J, Freitas G, Goncalves M, et al
    Impact of HPV vaccination after a diagnosis of cervical HSIL - a case-control study.
    Expert Rev Anticancer Ther. 2026;26:519-527.
    PubMed    
    Abstract available

  81. FENG X, Ginjupalli R, Lukhorito J, Karanja D, et al
    Cervical Cancer Screening with Visual Inspection with Acetic Acid (VIA) among Women Living with HIV in Nairobi, Kenya: Results and Transformation Zone.
    medRxiv [Preprint]. 2026 Mar 30:2026.03.27.26349550.
    PubMed    
    Abstract available

  82. ZHU F, Xie X, Wang C, Liu J, et al
    PIK3CA mutation-induced immune microenvironment remodeling sensitizes cervical cancer to immunotherapy.
    Front Immunol. 2026;17:1780752.
    PubMed    
    Abstract available

  83. YARZA R, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al
    The game changer in the cervical cancer therapeutic landscape: immunotherapy.
    Immunotherapy. 2026 Apr 10:1-17. doi: 10.1080/1750743X.2026.2647581.
    PubMed    
    Abstract available

  84. LEE SM, Seo H, Kim S, Cho HW, et al
    Prognostic significance of psoas muscle index at diagnosis in cervical cancer progression.
    J Gynecol Oncol. 2026 Mar 30. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  85. WANG S, Ma GF, Xiao C, Liu J, et al
    Adjuvant concurrent chemoradiotherapy for early-stage cervical cancer patients with intermediate-risk factors in the era of intensity-modulated radiation therapy.
    J Gynecol Oncol. 2026 Mar 19. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  86. PALAIA I, Perniola G, Tonti N, Tomao F, et al
    Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.
    J Gynecol Oncol. 2026 Mar 30. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  87. TAKAHASHI K, Takeda K, Takagi H, Niiyama A, et al
    Deep learning-based auto-contouring for organs at risk in three-dimensional image-guided brachytherapy for cervical cancer and endometrial cancer.
    J Appl Clin Med Phys. 2026;27:e70570.
    PubMed    
    Abstract available

  88. BUSARI DA, Ntekim A, John-Akinola YO, Adejumo PO, et al
    Financial toxicity and psychosocial distress of breast and cervical cancer patients at a tertiary healthcare facility in south-western Nigeria.
    BMC Womens Health. 2026 Apr 9. doi: 10.1186/s12905-026-04436.
    PubMed    


  89. INFANTE V, Miyaji KT, Martini CCR, Picone C, et al
    Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence and cervical lesions in systemic lupus erythematosus (SLE) and immunocompetent women.
    Lupus Sci Med. 2026;13:e001812.
    PubMed    
    Abstract available

  90. AUDIGER C, Chatignoux E, Rasia I, Serra-Jezewski D, et al
    Area-based socioeconomic inequalities in cervical cancer screening coverage in France.
    J Epidemiol Popul Health. 2026;74:203350.
    PubMed    
    Abstract available

  91. LIU X, Lei J
    PET-CT radiomics and artificial intelligence for predicting lymph node metastasis in cervical cancer: a systematic review and meta-analysis.
    Clin Transl Oncol. 2026 Apr 9. doi: 10.1007/s12094-026-04346.
    PubMed    
    Abstract available

  92. JIANG Y, Ren J, Tao J
    Ultrasound-Assisted Radiopharmaceutical Investigation of GNL1-Mediated AKT-P53-P21 Axis Activation in Cervical Cancer Progression.
    Cancer Biother Radiopharm. 2026 Apr 9:10849785261438424.
    PubMed    
    Abstract available

  93. MIAO JJ, Zhang XY, Zhang YX, Gao L, et al
    Comparison of long-term prognoses between 3D-printed template-guided and conventional freehand interstitial brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
    Front Oncol. 2026;16:1766456.
    PubMed    
    Abstract available

  94. FRANKLIN G, Henry C, Larsen P, Johnson C, et al
    "It Feels Like Another Thing Cancer Took From Me"- Exploring Cervical Cancer Patients' Experience of Financial Toxicity in Aotearoa, New Zealand.
    J Med Imaging Radiat Oncol. 2026 Apr 8. doi: 10.1111/1754-9485.70096.
    PubMed    
    Abstract available

  95. LENCHA B, Geda B, Ahmed K, Spigt M, et al
    Barriers and facilitators of adherence to cervical cancer screening follow-up among women living with HIV in South Ethiopia: a qualitative study.
    BMC Prim Care. 2026 Apr 8. doi: 10.1186/s12875-026-03303.
    PubMed    


  96. CHEISHVILI D, El-Zein M, Franco EL, Szyf M, et al
    Correction: ??Enhancing the sensitivity of non-invasive cervical cancer detection using CpG methylation haplotype profiling.
    Sci Rep. 2026;16:11751.
    PubMed    


  97. RICHARDS-MCDONALD L, Baptiste DL, Nettles B
    Addressing Inequalities in Cervical Cancer Screening: Nursing Strategies to Overcome Barriers and Improve Health Outcomes.
    Clin J Oncol Nurs. 2026;30:161-167.
    PubMed    
    Abstract available

  98. CHEN Y, Xie H, Wang S, Chen Y, et al
    Generation of deep learning based virtual contrast-enhanced CT images from noncontrast CT images for target volume delineation in cervical cancer radiotherapy.
    Front Oncol. 2026;16:1764560.
    PubMed    
    Abstract available

  99. NAMUTUNDU J, Nakalembe M, Kiguli J, Wanyenze RK, et al
    User-Centered Design of Strategies for Improving Cervical Cancer Screening Literacy Among Rural Women Living with HIV in Eastern Uganda.
    Patient Prefer Adherence. 2026;20:572018.
    PubMed    
    Abstract available

  100. PALMER C, Ovcinnikova-Hutchings O, Engelbrecht K, Favato G, et al
    Modelling the time to cervical cancer elimination in England: strategies for achieving elimination by 2040.
    BMJ Public Health. 2026;4:e004290.
    PubMed    
    Abstract available

  101. AZUBUIKE S, Adamu M
    Cervical cancer screening uptake and its determinants among rural women in North Central Nigeria: a cross-sectional study.
    Rural Remote Health. 2026;26:10433.
    PubMed    
    Abstract available

  102. HOSSEINI K, Alizadeh M, Jalilian A, Hoseini S, et al
    Silver nanoparticles combine with Nigella sativa oil to potentiate apoptosis in cervical cancer.
    Sci Rep. 2026;16:11446.
    PubMed    
    Abstract available

  103. PAPAGIANNAKOU V, Fradelos EC, Dimitriadou I, Saridi M, et al
    Missed Opportunities in Cervical Cancer Prevention: Knowledge and Screening Practices Among Women with Hemoglobinopathies in Greece.
    Asian Pac J Cancer Prev. 2026;27:1535-1542.
    PubMed    
    Abstract available

  104. YUTYUENYONG S, Punyashthira A, Poomtavorn Y, Suwannarurk K, et al
    Prediction Score of Cervical Intraepithelial Neoplasia Grade II or Higher (CIN2+) in Patients with Low-Grade Cytology (ASC-US, LSIL) and HPV- Negative or Non-type 16/18 High-Risk HPV-Positive Results.
    Asian Pac J Cancer Prev. 2026;27:1515-1522.
    PubMed    
    Abstract available

  105. WINATA IGS, Syofyan SD, Syofyan JF, Santoso RC, et al
    Bioinformatics Analysis Reveals Distinct Oncogenic Profiles of HPV-16 and HPT-18 to Other Subtypes in Cervical Cancer.
    Asian Pac J Cancer Prev. 2026;27:1505-1513.
    PubMed    
    Abstract available

  106. CHELLAT FZ, Bahra N, Chami Khazraji Y, Bekkali R, et al
    HPV Self-Sampling for Cervical Cancer Screening in Morocco: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2026;27:1249-1256.
    PubMed    
    Abstract available

  107. DANKAI W, Thangvorathum P, Pukdee K, Aithin P, et al
    Enhancing Cervical Cancer Screening Among Northern Thai Women: Satisfaction with Self-Collected HPV DNA Testing under the National Program.
    Asian Pac J Cancer Prev. 2026;27:1211-1217.
    PubMed    
    Abstract available

  108. A AM, M ZT, Tesfey T, Mulaw G, et al
    Phytochemical Analysis and Apoptosis-Inducing Anticancer Activity of Buddleja polystachia Leaf Extract against HeLa Cell Lines.
    Asian Pac J Cancer Prev. 2026;27:1201-1210.
    PubMed    
    Abstract available

  109. GABDULLINA M, Ainakulova A, Elboga U, Karibayeva I, et al
    Performance of [68Ga]Ga-FAPI PET in Breast, Ovarian, and Cervical Cancers: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2026;27:1161-1170.
    PubMed    
    Abstract available

  110. BUTLER S, Niedermayr T, Kidd E
    Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer.
    Brachytherapy. 2026 Apr 6:S1538-4721(26)00023.
    PubMed    
    Abstract available

  111. FAN X, Guo H, Wang S, Peng X, et al
    HPV16/18 Genotyping Combined With PAX1 Methylation Triage Reduces Immediate Colposcopy While Improving CIN3+ Detection: A Real-World Study of 3,233 Chinese Women.
    Cancer Control. 2026;33:10732748261442617.
    PubMed    
    Abstract available

  112. SHIRANE T, Kurahashi T, Takatsuji N, Nagai S, et al
    An In-Field Recurrent Cervical Cancer Case After Chemoradiotherapy With a Marked Response to Pembrolizumab Combined With TC (Paclitaxel-Carboplatin) Therapy: A Case Report.
    Cureus. 2026;18:e106460.
    PubMed    
    Abstract available

  113. SAVCI G, Sahin EA, Sahin H, Olcenoglu MF, et al
    Laparoscopic type 3 radical hysterectomy with enclosed colpotomy using the Bakay technique for early-stage cervical cancer: a retrospective case series.
    BMC Womens Health. 2026 Apr 6. doi: 10.1186/s12905-026-04442.
    PubMed    


  114. LIU Y, You J, Liu D, Wen L, et al
    Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of postoperative cervical cancer patients.
    Sci Rep. 2026 Apr 6. doi: 10.1038/s41598-026-42652.
    PubMed    
    Abstract available

  115. ALLON H
    The HPV vaccination programme and cervical cancer elimination.
    Br J Nurs. 2026;35:366-369.
    PubMed    
    Abstract available

  116. ZHU Y, Wang Q, Zhang Y, Liu Y, et al
    Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway.
    Clin Transl Med. 2026;16:e70652.
    PubMed    
    Abstract available

  117. TOBON-OSORNIO F, Arellano-Llamas AA, Perales-Flores PM, Torrecilla-Toledo CA, et al
    Change of Cervical Cancer Stage at Diagnosis After the COVID-19 Pandemic.
    Cureus. 2026;18:e104659.
    PubMed    
    Abstract available

  118. ATIBIOKE OP, Oyasope BT, Ojomo OA, Jima BW, et al
    A cross-sectional assessment of cervical cancer vaccination and screening among women of reproductive age living with HIV in North Central States, Nigeria.
    Pan Afr Med J. 2025;52:175.
    PubMed    
    Abstract available

  119. WU Y, Xue X, Su L, Liu Y, et al
    Effect of bladder volume on dose of exposure to dangerous organs and incidence of cystitis and enteritis in patients with cervical cancer after external radiotherapy.
    Front Oncol. 2026;16:1760076.
    PubMed    
    Abstract available

  120. ZHAO M, He W, Dai J, Xie Y, et al
    C2FAU-Net: A Deep Learning Approach with Multi-scale Strategy for Automated Delineation of Organs-at-risk in Cervical Cancer High-dose Rate Brachytherapy.
    J Med Phys. 2025;50:217-226.
    PubMed    
    Abstract available

  121. VASQUEZ GUZMAN CE, Hodes T, Lucas J, Marino M, et al
    Cervical Cancer Screening among Older Latina Migrant and Seasonal Farmworkers in a Network of Community Health Centers.
    Ethn Dis. 2026;35:165-172.
    PubMed    
    Abstract available

  122. TANG X, Zheng Q, Li X, Wang K, et al
    Integrated Multi-Omics Analysis Constructs an Intratumoral Heterogeneity-Corrected Prognostic Signature for Cervical Cancer.
    Int J Gen Med. 2026;19:593477.
    PubMed    
    Abstract available

  123. RADOJEVIC MZ, Jankovic K, Folic M, Spasic M, et al
    Nodal status in predicting the outcome of treatment with definitive chemoradiation in patients with cervical cancer in FIGO IIIC1 and IIIC2 stages.
    Rep Pract Oncol Radiother. 2026;31:96-106.
    PubMed    
    Abstract available

  124. AMADI A, Lawal M, Khan H, Japhet S, et al
    Bridging the gap: exploring healthcare professionals' perceptions and barriers towards cervical cancer screening services uptake amongst women in rural communities.
    J Egypt Natl Canc Inst. 2026;38:10.
    PubMed    


  125. MENG N, Wei W, Huang Z, Feng P, et al
    The Value of Time-dependent Diffusion MRI and Macromolecular Proton Fraction Imaging in Assessing Pathological Grade in Cervical Cancer.
    Acad Radiol. 2026 Apr 4:S1076-6332(26)00186-8. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available

  126. JOHN G, Ghanekar S, Dominic D, Gawde JR, et al
    Dynamic gamma-H2AX response in blood lymphocytes for prediction of radiotherapy induced bladder toxicity in cervical cancer patients.
    Indian J Med Res. 2026;163:11-18.
    PubMed    
    Abstract available

  127. YU Q, Wang M, Li Z, Yu X, et al
    Baicalein induces cervical cancer apoptosis via PTEN/PI3K/AKT pathway modulation.
    Pak J Pharm Sci. 2026;39:1759-1770.
    PubMed    
    Abstract available

  128. JIN P, Cheng Q, Hong X, Jia Q, et al
    Development of Covalent Small-Molecule Fluorescent Probes for DNA Methyltransferase 1 Detection in Cancer Cells and Cervical Exfoliated Cells.
    J Med Chem. 2026;69:8130-8147.
    PubMed    
    Abstract available

  129. TADELE S, Yilema A, Woldesemayat B, Zealiyas K, et al
    High-risk human papillomavirus genotype distribution, cytological abnormalities, and associated factors among Ethiopian women: a multicenter study.
    Microbiol Spectr. 2026;14:e0315425.
    PubMed    
    Abstract available

  130. HUANG X, Gao H, Xue H, Chen Y, et al
    Efficacy and influencing factors of photodynamic therapy in treating cervical low-grade squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2026;58:105426.
    PubMed    
    Abstract available

  131. HUSSAIN N, Haddad AHIA
    Immune-priming mechanisms of photodynamic therapy in cervical high-grade squamous intraepithelial lesions and translational implications for ovarian near-infrared photoimmunotherapy.
    Photodiagnosis Photodyn Ther. 2026;58:105406.
    PubMed    
    Abstract available

  132. STOLNICU S, Hoang L, Rakislova N, Horn LC, et al
    Cervical intraepithelial neoplasia: the expanding spectrum of cervical squamous intraepithelial lesions with focus on morphologic and molecular nuances.
    Virchows Arch. 2026;488:707-720.
    PubMed    
    Abstract available

  133. MA R, Jin Y, Lei Z, Sun P, et al
    Exploring adenoid basal carcinoma to squamous cell carcinoma of the uterine cervix transformation using spatial transcriptomics.
    J Pathol. 2026;269:86-99.
    PubMed    
    Abstract available

  134. CHEN M, Li L, Wang L, Zhu X, et al
    Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of cervical in low-grade squamous intraepithelial lesions combined with high-risk human papillomavirus in patients of childbearing age: A retrospective an
    Photodiagnosis Photodyn Ther. 2026;58:105380.
    PubMed    
    Abstract available

  135. SAKAMOTO M, Takeda S, Fujiwara A, Hirata M, et al
    Phase I/II clinical study of next-generation photodynamic therapy (L-PDT) using talaporfin sodium (Laserphyrin(R)) for cervical intraepithelial neoplasia: Efficacy, safety, and fertility preservation.
    Photodiagnosis Photodyn Ther. 2026;58:105372.
    PubMed    
    Abstract available

  136. GENG L, Mo W, Gao G, Liu Z, et al
    Comparative efficacy of topical 5-aminolevulinic acid versus Hiporfin photodynamic therapy in HPV-positive cervical intraepithelial neoplasia grade II.
    Photodiagnosis Photodyn Ther. 2026;58:105329.
    PubMed    
    Abstract available

  137. GRIMES DR, Brennan A, Walsh C
    A method of estimating cervical cancers prevented by the introduction of national screening in Ireland.
    Eur J Public Health. 2026;36:ckaf225.
    PubMed    
    Abstract available

  138. GONG N, Takeyama S, Yamaguchi M, Urata T, et al
    Papanicolaou stain unmixing for RGB image using weighted nucleus sparsity and total variation regularization.
    Med Biol Eng Comput. 2026;64:911-929.
    PubMed    
    Abstract available

  139. LI J, Ye Z, Gan Y, Li D, et al
    Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Curr Med Chem. 2026;33:1635-1650.
    PubMed    
    Abstract available

  140. ZHANG L, Yang J, Zhang P, Shang Y, et al
    Association between log odds of positive lymph nodes and survival in surgically treated cervical cancer patients: a SEER database-based cohort study.
    World J Surg Oncol. 2026 Apr 18. doi: 10.1186/s12957-026-04353.
    PubMed    


  141. WALLE M, Mulatie Z, Cherie N, Ibrahim AM, et al
    Hematological parameters as predictive indicators of disease stage in patients with cervical cancer.
    Sci Rep. 2026 Apr 17. doi: 10.1038/s41598-026-47004.
    PubMed    
    Abstract available

  142. HE G, Liang J, Ding Z, Qu X, et al
    KDM5B recruits FOXG1 to suppress the IFN response, leading to malignant progression and immune evasion in cervical cancer.
    Front Med (Lausanne). 2026;13:1749536.
    PubMed    
    Abstract available

  143. LI J, Su Y, Chen L, An Y, et al
    Association of CDK15 and L1CAM Expression in Cervical Cancer Tissues with Clinicopathological Characteristics and Recurrence/Metastasis After Radical Hysterectomy.
    Pak J Med Sci. 2026;42:621-628.
    PubMed    
    Abstract available

  144. IFEBI CO, Chigbu CO, Ajah LO, Aniebue UU, et al
    Cervical Cancer Screening among Human Immunodeficiency Virus-positive Women: A Comparison of Outcome between Visual Inspection with Acetic Acid and Papanicolaou Smear Cytology.
    Ann Afr Med. 2026 Apr 17. doi: 10.4103.
    PubMed    
    Abstract available

  145. SEMPRINI J
    RE: State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
    J Natl Cancer Inst. 2026 Apr 15:djag116. doi: 10.1093.
    PubMed    


  146. WU Y, Zhang Y, Qian X, Li Y, et al
    The association of fungal infection in cervical cancer: a systematic review and meta-analysis.
    BMC Womens Health. 2026 Apr 17. doi: 10.1186/s12905-026-04451.
    PubMed    
    Abstract available

  147. JIA M, Wapmuk A, Gbaja-Biamila T, Abudulrasheed OA, et al
    Knowledge, attitudes, and practices of cervical cancer preventive services among mothers living with HIV in Lagos, Nigeria: a cross-sectional study.
    BMC Public Health. 2026 Apr 16. doi: 10.1186/s12889-026-27320.
    PubMed    


  148. ZHONG P, Li W, Feng M, Guo A, et al
    METTL3-mediated m(6)A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis.
    Sci Rep. 2026 Apr 16. doi: 10.1038/s41598-026-47660.
    PubMed    


  149. TIAN D, Deng L, Lu E, Li H, et al
    Lactobacillus crispatus attenuates Escherichia coli-induced inflammation and migration of cervical cancer cells.
    AMB Express. 2026 Apr 16. doi: 10.1186/s13568-026-02055.
    PubMed    


  150. MSIBI SS, Lopez C, Khumalo FN, Su LJ, et al
    Predictors of survival among cervical cancer patients in Swaziland (Eswatini): A population-based analysis in a resource-limited setting (2016-2024).
    PLOS Glob Public Health. 2026;6:e0006309.
    PubMed    
    Abstract available

  151. CHERAGHI P, Khalaj-Kondori M, Moqadami A
    Epithelial-mesenchymal transition and its role in drug resistance of cervical cancer.
    Mol Biol Rep. 2026;53:618.
    PubMed    


  152. NOVAK EN, Ma A, Hansen CJ, Wazir Z, et al
    Mock Samples That Mimic Human Cervicovaginal Samples to Accelerate the Development and Evaluation of Assays for High-Risk HPV for Cervical Cancer Screening.
    J Med Virol. 2026;98:e70931.
    PubMed    
    Abstract available

  153. YAN Y DAGGER, Bai D dagger, Li L, Xu L, et al
    Distinct miR319a identified from Persicaria chinensis mediates cross-kingdom suppression of cervical cancer by targeting ITGA3.
    Acta Biochim Biophys Sin (Shanghai). 2026 Apr 13. doi: 10.3724/abbs.2026010.
    PubMed    
    Abstract available

  154. DA ROCHA KC, Castanha EB, Elias MEM, da Silva CML, et al
    Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo130.
    PubMed    
    Abstract available

  155. LI Q, Zeng J, Li X, Huang M, et al
    Case Report: Two cases of primary malignant melanoma of the female genital tract and literature review.
    Front Immunol. 2026;17:1797752.
    PubMed    
    Abstract available

  156. XIONG HY, Li R, Hu XM, Zhang Y, et al
    P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice.
    Purinergic Signal. 2026;22:39.
    PubMed    
    Abstract available

  157. MCCORMICK LJ, Gillot M, Ussery F, Bihini C, et al
    Cervical cancer screening coverage increased in Malawi, Tanzania, Zambia, and Zimbabwe: Findings from sequential Population-based HIV Impact Assessment Surveys 2015-2017 and 2020-2023.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003880.
    PubMed    
    Abstract available

  158. WOITTIEZ L, Soekdew A, Dams E, Brinkman K, et al
    Cervical Cancer Screening in Women Living With HIV in Suriname.
    Cureus. 2026;18:e105234.
    PubMed    
    Abstract available

  159. LEMOINE V, Legros R, Rosec S, Salaun C, et al
    Negative Xpert HPV Test (Cepheid) With Late Amplification Signals: Is There a Clinical Significance? (the PaPCR Study).
    J Med Virol. 2026;98:e70915.
    PubMed    
    Abstract available

  160. OLVERA-VALENCIA M, Grijalva-Perez A, Millan-Catalan O, Albino-Sanchez ME, et al
    Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models.
    Hereditas. 2026 Apr 14. doi: 10.1186/s41065-026-00668.
    PubMed    


  161. NING B, Liang X, Cui Z, Li Y, et al
    A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.
    Radiat Oncol. 2026 Apr 14. doi: 10.1186/s13014-026-02842.
    PubMed    
    Abstract available

  162. AHMADI M, Yoosefian M
    Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer.
    Sci Rep. 2026 Apr 14. doi: 10.1038/s41598-026-42656.
    PubMed    


  163. CHEN C, Zhang F, Shen J, Zheng Q, et al
    Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.
    Cell Death Discov. 2026;12:184.
    PubMed    


  164. LOU H, Langan D, Syracuse N, Murphy EA, et al
    PIK3CA mutant cervical cancer is selectively suppressed by PI3Kalpha inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.
    Neoplasia. 2026;76:101305.
    PubMed    
    Abstract available

  165. VILAKATI LN, Ndlela MG, Hlophe NP, Liu JJ, et al
    Comparison of early-onset and later-onset cervical cancer clinical characteristics and trends in Eswatini.
    Cancer Epidemiol. 2026;102:103071.
    PubMed    
    Abstract available

  166. LEVY MS, Huang M, Dietrich CS, Fabian D, et al
    Oncology Clinicians' Attitudes on Hormonal Therapy After Chemoradiotherapy for Cervical Cancer.
    JAMA Netw Open. 2026;9:e266862.
    PubMed    


  167. GUO L, Yuan X, Zhou Y, Zhang D, et al
    Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study.
    Clin Lab. 2026;72.
    PubMed    
    Abstract available


  168. Correction to: "Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy".
    J Appl Clin Med Phys. 2026;27:e70549.
    PubMed    


  169. PHIANPISET R, Detwongya C, Manopunya M, Cheewakriangkrai C, et al
    Prognostic Survival Model Following Primary Radical Surgery for Early-Stage Cervical Cancer.
    Cancers (Basel). 2026;18:1134.
    PubMed    
    Abstract available

  170. LANCELLOTTA V, La Milia MC, Autorino R, Rosa E, et al
    Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer.
    Cancers (Basel). 2026;18:1096.
    PubMed    
    Abstract available

  171. TRZESZCZ M, Mazurec K, Mazurec M, Kobierzycki C, et al
    Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining.
    Cancers (Basel). 2026;18:1056.
    PubMed    
    Abstract available

  172. KAMASHIDZE K, Beruchashvili T, Peshkova T, Nakashidze I, et al
    Physician-Level Determinants of Cervical Cancer Screening Practices: A Socio-Ecological Model-Based Study from Adjara, Georgia.
    Healthcare (Basel). 2026;14:961.
    PubMed    
    Abstract available

  173. GU Z, Liu Y, Liang Y, Lian X, et al
    Enhancing the precision and uniformity of clinical target volume delineation for cervical cancer through a structured educational program.
    BMC Med Educ. 2026 Apr 13. doi: 10.1186/s12909-026-09203.
    PubMed    


  174. CHOKWASSANASAKULKIT T, Ranasinghe V, Woods E, Nguyen LQ, et al
    What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?
    J Med Virol. 2026;98:e70916.
    PubMed    
    Abstract available

  175. YANG Y, Zhang G, Shang H, Fu X, et al
    Tumor apparent diffusion coefficient as a predictive marker for PD-1 inhibitor outcome in advanced cervical cancer: a retrospective study.
    Front Oncol. 2026;16:1769071.
    PubMed    
    Abstract available

  176. CHUGH M, Goel B, Sehgal A, Dubey S, et al
    Revolutionizing Community-Based Cervical Cancer Screening: Evaluating an Indigenous Artificial Intelligence-Enabled Portable Colposcope.
    J Obstet Gynaecol India. 2026;76:42-48.
    PubMed    
    Abstract available

  177. DONG S, Liu W, Yu D, Zhang X, et al
    Co-assembled structures of Fe(3)O(4) nanoparticles for therapy of cervical cancer by inducing apoptosis and autophagy.
    Transl Cancer Res. 2026;15:150.
    PubMed    
    Abstract available

  178. WANG ZX, Chang LL, Liu J, Wu DM, et al
    A retrospective cohort study comparing long-term clinical outcomes between patients with and without neoadjuvant therapy in stage IB-IIB cervical cancer: a propensity score-matched study.
    Transl Cancer Res. 2026;15:201.
    PubMed    
    Abstract available

  179. ABUZEYAD RN, Ali NA, Twalbeh DA
    Effect of a culturally tailored educational intervention on women's knowledge and attitudes toward cervical cancer screening: a single-group pre-post study.
    Womens Health Nurs. 2026;32:52-63.
    PubMed    
    Abstract available

  180. JIAN W, Zhu L, Zhang B, He Q, et al
    Megavoltage CT enhancement for cervical cancer tomotherapy using a generative adversarial network with deformable convolution and self-attention.
    Med Phys. 2026;53:e70416.
    PubMed    
    Abstract available

  181. QI W, Liao F, Luo Z, Shao M, et al
    Clinical and 18F-FDG PET/CT Imaging Characteristics of Post-radiotherapy Sacral Insufficiency Fractures in Cervical Cancer Patients.
    Curr Med Imaging. 2026 Apr 8. doi: 10.2174/0115734056428627260223054010.
    PubMed    
    Abstract available

  182. ZHAN F, Zhong Y, Qin Y, Li L, et al
    Retraction notice to "SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2" [Exp. Cell Res. 388 (2020) 111809].
    Exp Cell Res. 2026 Apr 10:115008. doi: 10.1016/j.yexcr.2026.115008.
    PubMed    


  183. BHETWAL B, Sharma V, Abbott A, Schafer EJ, et al
    Cervical cancer prevention behaviors and determinants among Indigenous women in rural Nepal.
    Health Promot Int. 2026;41:daag042.
    PubMed    
    Abstract available

  184. DONG X, Corbin H, Zhang X, Bai X, et al
    Comprehensive Assessment of Artificial Intelligence as a Stand-alone tool for Cervical Cancer Screening Using a 50% Negative Cutoff Value.
    Lab Invest. 2026 Apr 9:106126. doi: 10.1016/j.labinv.2026.106126.
    PubMed    
    Abstract available

  185. RAHMAN MT, Mahmood S, Attwell K
    Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh.
    Int J Health Policy Manag. 2026;15:9179.
    PubMed    
    Abstract available

  186. JIBA DF, Turay P, Baldeh M, Kamara MN, et al
    Human Papillomavirus Vaccine Hesitancy and Uptake Among Adolescent Girls Living with HIV in Sierra Leone: A Call for Integration of Cervical Cancer Services.
    AIDS Behav. 2026 Apr 11. doi: 10.1007/s10461-026-05065.
    PubMed    
    Abstract available

  187. LEI T, Wang F, Zhang S, Zhang L, et al
    Tumor Core-Edge Divergence in T-Cell Exhaustion and Clonal Expansion in HPV-Related Cervical Squamous Cell Carcinoma Unveiled by Simultaneous Single-Cell RNA and TCR Sequencing.
    J Med Virol. 2026;98:e70912.
    PubMed    
    Abstract available

  188. KOLIGUDDE V, Agarwal M, Marbaniang E, Shinde P, et al
    Beyond HPV-16 and 18: Clinical Significance of HPV-58 and 59 in Cervical Abnormalities in Northeast India.
    J Med Virol. 2026;98:e70924.
    PubMed    
    Abstract available

  189. ATTALLAH O
    Light-XAI: a CADx for explainable cervical cancer detection via attention-based lightweight convolutional neural networks and layer-wise feature fusion.
    BioData Min. 2026;19:26.
    PubMed    
    Abstract available

  190. LI Z, Zhao Z, Zhang Y, Xie Z, et al
    A nanoplatform for hypoxia-responsive co-delivery of an NQO1 enzyme-responsive pterostilbene prodrug and phenanthriplatin for multi-mechanistic cervical cancer therapy.
    Biochim Biophys Acta Mol Cell Res. 2026 Apr 8:120145.
    PubMed    
    Abstract available

  191. MONTIEL S, Pasaca C, Lopepe M, Gorosito F, et al
    [Post-hysterectomy chyloascites: A rare complication].
    Medicina (B Aires). 2026;86:526-528.
    PubMed    
    Abstract available

  192. DAI Y, Huang F, Li X, Wu W, et al
    Development and preclinical evaluation of KDTV001, an adenovirus 5-vectored trivalent HPV therapeutic vaccine targeting HPV16/18/52.
    EBioMedicine. 2026;126:106230.
    PubMed    
    Abstract available

  193. HUANG CY, Chang CY, You SL, Tsai HT, et al
    Recurrent cytologic inflammation on cervical smear and risk of low-grade cervical abnormalities in cytology-based screening: A 25-year multicenter cohort study from HPV-resource-limited settings.
    J Infect Public Health. 2026;19:103192.
    PubMed    
    Abstract available

  194. GE Z, Wang X, Zhang Z, Li J, et al
    Synchronous atypical lobular endocervical glandular hyperplasia of the cervix and endometrium: a clinicopathologic case report and review of literature.
    J Med Case Rep. 2026;20:191.
    PubMed    
    Abstract available

  195. JAHAN N, Hossain MS, Ariful Kabir KM
    Analyzing the impact of gender-specific vaccination strategies and behavioral dynamics on HPV transmission.
    Sci Rep. 2026;16:12115.
    PubMed    
    Abstract available

  196. CHIBWESHA CJ, Mollan KR, Teodoro NS, Keys JR, et al
    Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).
    Contemp Clin Trials. 2026;164:108272.
    PubMed    
    Abstract available

  197. MARTIN-NOGUEROL T, Lopez-Ubeda P, Barrientos-Manrique EA, Garcia-Ferrer M, et al
    Towards Automated FIGO Staging in Radiology: The Role of LLMs in Cervical and Endometrial Cancer.
    Acad Radiol. 2026;33:1545-1555.
    PubMed    
    Abstract available

  198. BOCHNIAK K, Nitsch-Osuch A, Zamudio Padilla JD, Prusaczyk A, et al
    Systemic recommendations on the promotion of HPV vaccinations based on international social marketing campaigns.
    Ginekol Pol. 2026;97:233-238.
    PubMed    
    Abstract available

  199. PAVONE M, Teodorico E, Bizzarri N, Innocenzi C, et al
    From Avoiding Empty Packets to Real-Time Diagnosis: The Value of Robotic Ultrasound-Guided Surgery in Sentinel Lymph Node Dissection.
    Ann Surg Oncol. 2026;33:4763-4764.
    PubMed    
    Abstract available

  200. RYAN M, Riain CO, Thodi G, Finn S, et al
    Dedifferentiated Cervical Mesonephric Adenocarcinoma: Report of 2 Cases of a Previously Undescribed Phenomenon.
    Int J Gynecol Pathol. 2026;45:210-216.
    PubMed    
    Abstract available

  201. KABARAMBI A, Kizito S, Girma AZ, Nartey P, et al
    Preliminary Impact of Public Health Messaging on HPV Vaccine Uptake Among Adolescent Girls and Young Women Living with HIV in Central Uganda.
    AIDS Behav. 2026;30:1202-1210.
    PubMed    
    Abstract available

  202. BONAR G, Cameron S
    Human papillomavirus vaccination and cervical screening uptake among women presenting for abortion: exploring opportunities for health care interventions.
    BMJ Sex Reprod Health. 2026;52:95-100.
    PubMed    
    Abstract available

  203. ABBAS S, Teague K, Lakin K, Bari K, et al
    Cervical Screening Experiences among Culturally and Linguistically Diverse Muslim Women in Australia: A Scoping Review.
    J Immigr Minor Health. 2026;28:489-504.
    PubMed    
    Abstract available

  204. XU J, Li Q, Weisman PS
    HPV-associated Endocervical Adenocarcinoma In Situ (AIS) With an ER+/Vimentin+/CEA- immunophenotype Mimicking Tubo-endometrioid Metaplasia.
    Int J Gynecol Pathol. 2026;45:246-248.
    PubMed    
    Abstract available

  205. HELLSTEN C, Forslund O, Borgfeldt C
    Real-world evaluation of a population-based vaginal self-sampling program for cervical cancer prevention in Region Skane, Sweden.
    Acta Obstet Gynecol Scand. 2026 Apr 8. doi: 10.1111/aogs.70206.
    PubMed    
    Abstract available

  206. KLOPP AH
    Longitudinal Profiling of Cervical Cancers Reveals Therapy-Induced Vulnerabilities Beyond the Checkpoint.
    Cancer Res. 2026;86:1540-1542.
    PubMed    
    Abstract available

  207. ZHOU S, Chen S, Xu S
    Establishment of a Methodology for PAX1 and CADM1 Methylation Detection and Preliminary Assessment of Its Clinical Value for Cervical Cancer Diagnosis.
    Diagn Cytopathol. 2026 Apr 16. doi: 10.1002/dc.70123.
    PubMed    
    Abstract available

  208. CHALIF J, Morton M, Gonzalez A, McLaughlin E, et al
    Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.
    Gynecol Oncol. 2026;208:77-84.
    PubMed    
    Abstract available

  209. SAVROVA A, Jakoby H, Tisler A, Innos K, et al
    Nationwide Study on the Cervical Cancer Screening Pathway in Estonia.
    Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70466.
    PubMed    
    Abstract available

  210. DOMINONI M, Rasore G, Pano MR, Gardella B, et al
    "Side effects" of cervical cancer screening: How diagnosis can impact on women's emotional status. A pilot survey.
    Int J Gynaecol Obstet. 2026 Apr 2. doi: 10.1002/ijgo.71005.
    PubMed    


  211. TJALMA W
    Letter to the Editor: Sentinel node biopsy in cervical cancer during pregnancy: The need for clarification in FIGO guidance.
    Int J Gynaecol Obstet. 2026 Mar 27. doi: 10.1002/ijgo.70986.
    PubMed    


  212. JIAMSET I, Nanthamongkolkul K, Kongkamsuan W, Saeaib N, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection.
    Int J Gynaecol Obstet. 2026 Apr 14. doi: 10.1002/ijgo.71016.
    PubMed    
    Abstract available

  213. PAREJA R, Agusti N, Vieira S, Mora-Soto N, et al
    Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review.
    Int J Gynecol Cancer. 2026;36:102729.
    PubMed    
    Abstract available

  214. LI L, You J, Yuan Y, Gu X, et al
    Prophylactic extended-field radiotherapy with concurrent chemotherapy for locally advanced cervical cancer: a propensity-score matching analysis.
    Int J Gynecol Cancer. 2026;36:104634.
    PubMed    
    Abstract available

  215. PAULO DOS SANTOS O, Rodrigues de Bastos D, Saddi VA, Termini L, et al
    Association of NK6 homeobox 1 promoter methylation with HPV infection, histological sub-type, and patient outcomes in cervical lesions.
    Int J Gynecol Cancer. 2026;36:104561.
    PubMed    
    Abstract available

  216. DONOHOE F, Cohen A, Castillo A, Dagher C, et al
    Pre-operative imaging in clinical International Federation of Gynecology and Obstetrics stage IB2 or less cervical carcinoma.
    Int J Gynecol Cancer. 2026;36:104562.
    PubMed    
    Abstract available

  217. KIM DY, Lee CW, Jung W, Kang HC, et al
    Treatment of cervical/vaginal intra-epithelial neoplasia with high-dose-rate brachytherapy: a multi-center retrospective analysis.
    Int J Gynecol Cancer. 2026;36:104466.
    PubMed    
    Abstract available

  218. SONG M, Bandoni K, Rodriguez-Rodriguez L, Nelson RA, et al
    Disparities between Blacks and Whites in risk of second primary malignancies among patients with cervical cancer: analysis of Surveillance, Epidemiology, and End Results Database.
    Int J Gynecol Cancer. 2026;36:104637.
    PubMed    
    Abstract available

  219. SILVA NETO ALD, Mattos JM, Scaranti M
    Beyond viral detection: refining biological risk stratification in human papillomavirus-positive cervical cancer screening.
    Int J Gynecol Cancer. 2026;36:104658.
    PubMed    


  220. VANDECAVEYE V, Walgraeve MS, De Keyzer F, Vergote I, et al
    Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapy.
    Int J Gynecol Cancer. 2026;36:104650.
    PubMed    
    Abstract available

  221. CHO O, El Naqa I
    Prognostic impact of pelvic bone magnetic resonance imaging features in patients with cervical cancer undergoing definitive concurrent chemoradiotherapy.
    Int J Gynecol Cancer. 2026;36:104648.
    PubMed    
    Abstract available

  222. LUO R, Chen J, Chen Z, Wang S, et al
    MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
    Oncol Rep. 2026;55:101.
    PubMed    
    Abstract available

  223. ANDREADIS G, Groot W, Boer SM, Bosman PAN, et al
    Interobserver variability of corresponding anatomical landmark placement in pelvic CT and MRI scans.
    Radiother Oncol. 2026;218:111430.
    PubMed    
    Abstract available

  224. USIN SG, Olajire GA, Olumese JO, Idenyi EO, et al
    Transcriptomic profiling of select genes associated with cervical cancer and its preneoplastic lesions in Nigerian patients: an in vivo and in silico study.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15972.
    PubMed    


  225. SORI DA, Ali R, Jibat N, Adissu W, et al
    Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15987.
    PubMed    


  226. YANG X, Xie Y, Gao C, Sun N, et al
    Noninvasive prediction of lymph-vascular space invasion in cervical cancer based on ultrasomics nomogram.
    BMC Cancer. 2026 Apr 13. doi: 10.1186/s12885-026-15981.
    PubMed    


  227. ZHAO Y, Zhao C, Liu Y, Wang Y, et al
    Prognostic prediction in primary cervical squamous cell carcinoma with serum squamous cell carcinoma antigen >/= 10 ng/mL: development and validation of a nomogram model based on inflammatory biomarkers and clinical factors.
    BMC Cancer. 2026;26:479.
    PubMed    
    Abstract available

  228. SHIRAKAWA S, Nagao S, Yoshio K, Mitsuhashi T, et al
    Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
    PLoS One. 2026;21:e0344384.
    PubMed    
    Abstract available

  229. EMESU G, Kiracho EE, Jatho A, Kagaayi J, et al
    Equity in awareness and utilization of cervical cancer screening services among women of reproductive age in Uganda: Analysis of vertical equity using evidence from UDHS 2022.
    PLoS One. 2026;21:e0335336.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;